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ABSTRACT
Black and Hispanic communities in the U.S. have endured a disproportionate burden of COVID19-related morbidity and mortality. Racial and ethnic health disparities such as these are
frequently aggravated by inequitable access to healthcare resources in disadvantaged
communities. Yet, no known studies have investigated disadvantaged communities’ access to
COVID-19-related healthcare resources. The current study accordingly examined racial and
ethnic differences in (1) April 2020 COVID-19 total and positive viral test rates across 177 New
York City (NYC) ZIP Code Tabulation Areas (ZCTA); and (2) November 2019-April 2020
licensed and intensive care unit (ICU) hospital bed access across 194 NYC ZCTAs. Pairwise
analyses indicated higher COVID-19 total and positive test rates per 1,000 persons in majority
Black and Hispanic vs. majority White ZCTAs (CI [0.117, 4.55]; CI [2.53, 5.14]). Multiple
linear regression analyses indicated that higher percentage of Black and Hispanic residents
predicted more total COVID-19 tests per 1,000 persons (p<0.05). In contrast, majority Black and
Hispanic ZCTAs had fewer licensed and ICU beds (CI [6.50, 124.25]; CI [0.69, 7.16]), with
social disadvantage predicting lower licensed and ICU bed access per 1,000 persons (p<0.01).
While anecdotal reports of inequitable access to COVID-19-related healthcare resources in
ethnocultural minority communities have emerged, this is the first study to reveal that social
disadvantage may be a major driver of hospital resource inequities in Black and Hispanic
communities. Thus, it will be imperative to enact policies that ensure equitable allocation of
healthcare resources to socially disadvantaged communities to address current and future public
health crises.
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INTRODUCTION
Socially disadvantaged communities in the U.S. have borne a disproportionate burden of
COVID-19-related morbidity and mortality, with Black and Hispanic communities enduring
among the nation’s heaviest rates of COVID-19 incidence and deaths—paralleling prior viral
pandemics (Centers for Disease Control and Prevention, 2020a, 2020b; Garg, 2020; Hutchins et
al., 2009). These disparate COVID-19-related morbidity and mortality rates reflect a
longstanding history of systemic racism, which has produced limited socioeconomic
opportunities and unjust social conditions in U.S. racial/ethnic minority communities that
contribute to glaring health disparities (Boyd et al., 2020; Poteat et al., 2020). For example,
without a universal healthcare system in the U.S., Black and Hispanic Americans are frequently
faced with inequitable access to expensive, robust health insurance exchanges (Kirby & Kaneda,
2005; Poteat et al., 2020). This correspondingly leads to high out-of-pocket healthcare costs that
discourage help-seeking behaviors and health service use for treating chronic diseases, such as
obesity and diabetes, which (1) are more prevalent among Black and Hispanic compared to
White Americans, and (2) have been identified as comorbidities known to exacerbate COVID-19
severity (Carnethon Mercedes R. et al., 2017; Richardson et al., 2020). This linear accumulation
of inequities illustrates heightened COVID-19-related risk, while serving as a harbinger of the
cumulative impact of systemic inequities plaguing socially disadvantaged communities in the
U.S. (Chowkwanyun & Reed, 2020; Williams & Cooper, 2020).
According to theories around social determinants of health, racial and ethnic health
disparities are largely a function of inequitable access to health-promoting living and working
conditions (Braveman et al., 2011). For example, Blacks and Hispanics are more likely to live in
underresourced neighborhoods that lack access to key healthcare resources (Kirby & Kaneda,
2005). Fundamental cause theory posits that racial and ethnic disparities in new diseases are
driven not by a disease’s specific characteristics or risk factors but by social determinants—e.g.,
socioeconomic status, residential segregation—that inhibit disadvantaged groups’ access to
essential health-protective resources for avoiding disease (Centers for Disease Control and
Prevention, 2020a; Phelan et al., 2010). This theory discloses the critical influence that unequal
access to health-protective resources may have in driving COVID-19-related health disparities.
Yet, no known studies have examined access to essential COVID-19-related healthcare resources
(i.e., viral tests, hospital beds) in Black and Hispanic communities, or the extent to which social
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disadvantage predicts access to these resources. This, in turn, has limited policymakers’ ability to
target and reduce COVID-19-related racial and ethnic disparities (Morrison, 2020).
To address this gap, we compared access to COVID-19-related resources of viral testing
and licensed (i.e., the number of beds any given hospital is licensed to operate) and intensive
care unit (ICU) hospital beds in majority Black and Hispanic vs. majority White communities in
New York City (NYC). NYC has one of the nation’s largest hospital systems—comprising acute
care, community, teaching, and research hospitals—which includes the NYC Health+ public
hospital system that serves patients on publicly subsidized health insurance exchanges
(Medicare, Medicaid), as well as those that do not have health insurance. We examined NYC
because it possessed the nation’s most COVID-19 cases during the April 2020 peak in morbidity
and mortality, with approximately 6,206 positive test cases, 1,682 hospitalizations, and 571
confirmed deaths reported on April 6, 2020: NYC’s single worst day of COVID-19-related
morbidity and mortality (NYC Health, 2020b). Finally, with NYC Black and Hispanic
populations bearing a disproportionate COVID-19 burden—age-adjusted rates of hospitalized
cases and fatalities per 100,000 persons as of May 13, 2020 of 448.3 and 265.0 for Blacks and
367.7 and 259.2 for Hispanics vs. 195.6 and 130.3 for Whites, respectively (NYC Health,
2020b)—examining the distribution of healthcare resources before and during the April 2020
COVID-19 peak in NYC may serve to inform policies and practices that effectively reduce these
notable health disparities.
METHODS
Data
Using NYC Department of Health and Mental Hygiene data from April 6, 2020 (NYC
Health, 2020b), we identified all NYC Zip Code Tabulation Areas (ZCTA) with publiclyreported COVID-19 testing data, then classified each ZCTA as composed of either majority
Black and Hispanic (i.e., ≥ 51% Black and Hispanic) or majority White (i.e., ≥ 51% nonHispanic White). With the vast COVID-19 disparities in Black and Hispanic communities, this
classification served to (1) illustrate resource disparities in these communities, while (2)
accounting for the considerable overlap of Black and Hispanic residents within NYC ZCTAs.
Study analyses were situated at the ZCTA unit of analysis, with the following COVID-19-related
resource variables by ZCTA: (1) total and positive COVID-19 tests per 1,000 persons, and (2)
November 2019, March 2020, and April 2020 licensed and ICU hospital bed counts for all NYC
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hospitals with 24-hour emergency departments treating COVID-19 patients (Melby et al., 2020;
NYC Health, 2020a). This study utilized publicly available data aggregated to ZCTAs that did
not involve human subjects, and was thus determined to be exempt from ethical compliance by
the Chapman University Institutional Review Board.
To calculate licensed and ICU hospital bed variables, we geolocated all hospitals meeting
the above criteria, identified each hospital’s total number of licensed and ICU beds (Melby et al.,
2020; NYC Health, 2020a), and mapped total licensed and ICU beds per 1,000 persons within
1.22 miles of each ZCTA centroid (generating 2.44 mile buffers) to match U.S. residents’
average distance of 2.44 miles to the nearest hospital (Centers for Disease Control and
Prevention, 1999). Finally, we collected 2018 American Community Survey 5-Year data to
obtain ZCTA population density, percent Black and Hispanic, percent female, percent over 50
years of age, median household income, and percent unemployment (U.S. Census Bureau, 2018).
All data were joined at the ZCTA-level in ArcMap v.10.5.
Statistical Analysis
Analyses were conducted in IBM SPSS v.25. We calculated mean number of
licensed/ICU hospital beds per 1,000 persons within 1.22-mile buffers of each NYC ZCTA
centroid for November 2019 (pre-pandemic), and March (early pandemic) and April (pandemic
peak in NYC) 2020 to illustrate temporal resource change in response to the dramatic increase in
COVID-19 related morbidity and mortality. Independent t-tests compared majority Black and
Hispanic vs. majority White ZCTAs for April 6, 2020 (1) total and positive COVID-19 tests per
1,000 persons (n=177 ZCTAs with publicly-available testing data); and (2) licensed and ICU
hospital beds per 1,000 persons (n=194). To explore associations between COVID-19 resources
and social disadvantage, three stepwise multiple linear regression models were developed with
dependent variables—per 1,000 persons—consisting of total tests, licensed beds, and ICU beds,
respectively, regressed by (step 1) demographic variables of ZCTA population density, percent
Black and Hispanic, percent female, and percent over 50 years of age; and (step 2) social
disadvantage variables of median household income and percent unemployment. Variance
inflation factors were below 2.60.
RESULTS
As seen in Figure 1, in November 2019, per 1,000 persons, majority White ZCTAs had
on average 69.5 licensed beds whereas majority Black and Hispanic ZCTAs had 8.0 beds—a
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striking disparity in pre-pandemic resources. On March 26, 2020, with the COVID-19 epidemic
overwhelming NYC hospital systems, licensed beds per 1,000 persons increased in majority
White ZCTAs to 73.5 beds vs. 8.4 beds in majority Black and Hispanic ZCTAs. By April 6,
2020—the single day peak of COVID-19 cases in NYC—mean licensed beds per 1,000 persons
increased to 75.5 in majority White vs. 10.1 in majority Black and Hispanic ZCTAs.

Figure 1: Licensed Hospital Beds Per 1,000 Persons in New York City Zip Code Tabulation
Areas by Date by Race and Ethnicity
Independent t-tests indicated that COVID-19 total and positive tests were higher per
1,000 persons in majority Black and Hispanic vs. majority White ZCTAs (t=2.08, 95% CI
[0.117, 4.55]; t=5.79, 95% CI [2.53, 5.14]), with 23.3 vs. 21.0 total tests and 14.2 vs. 10.4
positive tests, respectively. Yet, despite having higher COVID-19 positive test rates—suggesting
greater COVID-19 burden and resource need—by April 6, majority Black and Hispanic ZCTAs
still had fewer licensed and ICU beds per 1,000 persons vs. majority White ZCTAs (t=2.21, 95%
CI [6.50, 124.25]; t=2.41, 95% CI [0.69, 7.16]), with differences of 10.1 vs. 75.5 licensed
hospital beds and 0.4 vs. 4.4 ICU beds per 1,000 persons, respectively.
Regressions indicated that our predictor demographic and social disadvantage variables
accounted for 28.0%, 20.0%, and 22.7% of the variance for our three COVID-19-related
resource variables of total tests, licensed beds, and ICU beds per 1,000 persons, respectively. For
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the total tests model, ZCTA percent Black and Hispanic and percent over 50 years of age
significantly predicted (p<0.05) increases in total COVID-19 tests administered per 1,000
persons, whereas population density significantly predicted (p<0.001) decreases in total COVID19 tests administered per 1,000 persons (Table 1). For both beds models, population density,
percent female, and median household income significantly predicted (p<0.05) licensed and ICU
bed increases per 1,000 persons (Table 1). Notably, ZCTA percentage Black and Hispanic
significantly predicted licensed and ICU bed decreases in Step 1, but did not in Step 2 after
accounting for our social disadvantage variables of median household income and percent
unemployment.
Total Tests
R2
Step 1

β

(95% CI)

0.29***

Population Density

Percent Female
Percent Age 50+ Years
0.28

Median Household Income
Percent Unemployment

β

(95%
CI)

0.15***
-0.367*** (-0.00012,
-0.00005)
0.216*
(0.003,
0.100)
-0.088
(-0.674,
0.163)
0.275***
(0.147,
0.484)

Percent Black/Hispanic

Step 2

Licensed Beds
R2

β

(95% CI)

0.17***
0.275*** (0.001,
0.002)
0.095 (-0.537,
1.446)
0.177* (1.488,
18.008)
-0.106 (-1.258,
5.581)

0.20**
0.003 (-0.000043,
0.000042)
-0.038
(-0.623,
0.424)

ICU Beds
R2

0.280*** (0.000031,
0.000099)
0.072
(-0.032,
0.066)
0.189**
(0.113,
0.924)
-0.086
(-0.080,
0.255)
0.23***

0.253** (0.001,
0.003)
-.150
(18.507,
2.911)

0.259** (0.000015,
0.000096)
-0.164
(-0.951,
-0.100)

Table 1. Regression of predictor variables on total tests, licensed beds, and ICU beds per 1,000 persons.
Boldface indicates statistical significance (*p<0.05 **p<0.01 ***p<0.001). Final model β reported.
DISCUSSION
Study findings revealed that during the March-April COVID-19-related surge in hospital
bed capacity throughout NYC, despite bearing a disproportionate burden of COVID-19-related
hospitalizations and deaths, majority Black and Hispanic communities—which possessed
dramatically lower pre-pandemic bed capacities—continued to suffer alarming disparities in bed
capacity vs. majority White communities (Centers for Disease Control and Prevention, 2020b;
Garg, 2020). While some patients were transferred to hospitals in more affluent areas that could
accommodate them, this highly inequitable access to healthcare resources during the surge
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mirrors the well-publicized installation of 2,500 emergency hospital beds within predominantly
White, high-income locations including Manhattan’s Javits Center and Pier 90, and Brooklyn
Cruise Terminal, while patients in nearby majority Black and Hispanic-serving hospitals (e.g.,
Elmhurst Hospital) perished due to inadequate bed capacities (Dwyer, 2020).
More positively, when we examined COVID-19 testing rates, majority Black and
Hispanic communities completed more tests, possibly indicating that NYC officials
appropriately allocated viral testing resources to communities based on need. All testing in NYC
was free and confidential, with hundreds of testing sites and mobile testing units throughout the
city. Thus, directly addressing cost, anonymity, and geographic accessibility of viral testing may
have encouraged help-seeking behaviors and health service use within NYC’s Black and
Hispanic communities, paving the way for curbing the cumulative impact of broader health
disparities and systemic inequities (Braveman et al., 2011; Poteat et al., 2020). Unfortunately,
COVID-19 positive test rates were higher in majority Black and Hispanic communities,
indicating that Black and Hispanic residents may have been hindered by limited access to healthpromoting living and working conditions. Furthermore, access to licensed and ICU beds in
majority Black and Hispanic communities remained shockingly low despite the surge, with this
disparity appearing to be partially accounted for by median household income in our regressions.
Thus, our findings align with fundamental cause theory in suggesting that social disadvantage, as
evidenced by median household income in this study, was a primary driver of inequitable
hospital bed access that affected NYC’s Black and Hispanic communities during the COVID-19
crisis (Phelan et al., 2010).
There are several limitations to the current study. First, the study may have benefitted
from supplementary analyses accounting for access to additional health-promoting resources
such as health clinics, COVID-19 viral testing centers, and personal protective equipment (e.g.,
N95 respirators and surgical masks). Second, ZCTA-level analyses of prevalence of
comorbidities known to associate with COVID-19 severity (e.g., obesity, diabetes, hypertension)
may have provided a more robust understanding of Black and Hispanic morbidity and mortality
in the NYC context (Richardson et al., 2020). Third, ZCTA-level race and ethnic total and
positive viral testing data have yet to be released, thus limiting our ability to identify COVID-19related health disparities within ZCTAs. Fourth, we recognize that ZCTA-level total and positive
viral testing data may not fully characterize the COVID-19 burden in NYC’s Black and Hispanic
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communities. Finally, we were unable to make causal inferences due to the cross-sectional
design of this study.
CONCLUSION
Without a universal healthcare system, appropriate allocation of limited life-saving
resources to overwhelmed hospital systems in disadvantaged communities is critical to reducing
morbidity and mortality during public health crises. News reports have revealed that while NYC
hospitals serving disadvantaged communities were besieged by COVID-19 patients, driving
mortality rates, some patients were eventually transferred to hospitals in less affected, more
affluent communities possessing thousands of empty critical-care beds (Dwyer, 2020). However,
temporary solutions such as these that attempt to compensate for the lack of an integrated
healthcare system only highlight longstanding systemic racism that has contributed to
community-level resource inequities that compromise health and well-being in disadvantaged
communities. Finally, policies stemming from systemic racism, which have historically limited
access to socioeconomic and healthcare resources in Black and Hispanic communities in the U.S.
(Boyd et al., 2020; Poteat et al., 2020), may have contributed to inequitable mortality rates in
NYC. Therefore, addressing systemic racism and long-standing resource inequities will be
critical to redressing racial and ethnic health disparities in U.S. communities.
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